Mutations in PIK3CA are among the most frequent in solid tumors, and especially in estrogen receptor (ER)-positive breast cancer (Ellis and Perou, 2013; Pereira et al., 2016; Razavi et al., 2018). This evidence concerns the gene PIK3CA and breast cancer.